Physician profile
Ryan Penrod
NPI 1205238870
$1,780.86
in general payments reported to CMS, 2019-2025
15 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.34 · 2022: $301 · 2023: $682 · 2024: $318 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345 · Education: $99.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,345.16 |
| Education | $99.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $531.24 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $264.37 | 2023-2025 | Dificid, Zerbaxa, Delstrigo |
| Gilead Sciences, INC. | $230.53 | 2022-2025 | |
| Lilly USA, LLC | $155.53 | 2023-2024 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $136.59 | 2023-2025 | Cresemba |
| Melinta Therapeutics, LLC | $112.41 | 2023-2025 | Vabomere, Rezzayo, Kimyrsa |
| Paratek Pharmaceuticals, INC. | $74.49 | 2023-2025 | Nuzyra |
| Shionogi INC | $68.93 | 2023-2025 | Fetroja |
| Aimmune Therapeutics, INC. | $49.90 | 2025 | Vowst |
| Abbott Laboratories | $49.03 | 2023-2024 | Assurity, Tacticath Ablation Catheter, Sensor Enabled |
| Biowound Solutions, INC. | $28.61 | 2025 | Bio-Connekt |
| Novo Nordisk INC | $26.72 | 2023 | Rybelsus |
| Insmed, INC. | $25.26 | 2025 | Arikayce |
| Ferring Pharmaceuticals INC. | $19.87 | 2023 | Rebyota |
| Advanced Oxygen Therapy INC. | $7.38 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Penrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.